Voriconazole And Anidulafungin Combination For Invasive Aspergillosis In Pediatric Subjects

NCT01188759 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Aspergillosis
Invasive Pulmonary Aspergillosis
Neuroaspergillosis

Interventions

DRUG: Voriconazole
DRUG: Anidulafungin
DRUG: Voriconazole

Sponsor

Pfizer